Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Intellia Therapeutics (NTLA) Return on Assets (2016 - 2025)

Historic Return on Assets for Intellia Therapeutics (NTLA) over the last 10 years, with Q3 2025 value amounting to 0.49%.

  • Intellia Therapeutics' Return on Assets fell 800.0% to 0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.39% for FY2024, which is 600.0% down from last year.
  • As of Q3 2025, Intellia Therapeutics' Return on Assets stood at 0.49%, which was down 800.0% from 0.5% recorded in Q2 2025.
  • In the past 5 years, Intellia Therapeutics' Return on Assets registered a high of 0.2% during Q4 2021, and its lowest value of 0.5% during Q2 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.35% (2022), whereas its average is 0.35%.
  • Per our database at Business Quant, Intellia Therapeutics' Return on Assets surged by 1200bps in 2021 and then plummeted by -1600bps in 2022.
  • Intellia Therapeutics' Return on Assets (Quarter) stood at 0.2% in 2021, then plummeted by -70bps to 0.35% in 2022, then dropped by -6bps to 0.37% in 2023, then dropped by -12bps to 0.41% in 2024, then fell by -19bps to 0.49% in 2025.
  • Its last three reported values are 0.49% in Q3 2025, 0.5% for Q2 2025, and 0.46% during Q1 2025.